ArticleJournal of orthopaedic case reports2026
Zoledronic Acid in the Management of Melorheostosis of Radius and Ulna - A Rare Case Report with Literature Review.
Article in Journal of orthopaedic case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Melorheostosis is an exceptionally rare mesodermal mixed sclerosing bone dysplasia that sometimes affects the surrounding soft tissue. There are no established guidelines for its management, as it is not a curable condition. Treatment primarily focuses on symptom relief and necessitates a coordinated multimodal approach involving orthopedics, physical medicine and rehabilitation, and pain management to achieve optimal results. Bisphosphonates have shown efficacy in this condition, alleviating pain and reducing disease severity. The literature contains only nine reports concerning the use of zoledronate in the treatment of melorheostosis. Case Report: We report a case involving a 24-year-old female diagnosed with melorheostosis affecting the radius and ulna, accompanied by subcutaneous hemangiomatosis, which was effectively managed with intravenous zoledronate and physiotherapy. Conclusion: This case report emphasizes the key characteristics of melorheostosis, the involvement of soft-tissues in this condition, and the application of zoledronate in its treatment, while highlighting the need for and potential of future research in this area.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.